Monitoring the Calm Before the Storm: A Video Capsule Endoscopy-guided Proactive Treat-to-target Approach in Crohn’s Disease
As the global burden and presence of inflammatory bowel diseases (IBDs) continues to increase, the treat-to-target paradigm has emerged as a central tenet of the care of patients with IBD.1 Goals for therapeutic targets for Crohn’s disease (CD) in particular may include clinical response, clinical remission, endoscopic remission, or normalization of biomarkers, but may reach as far as transmural remission, and/or histological remission.2 These targets are increasingly being included in randomized controlled clinical trials and their optimal use is evolving.
